SIDERO BIOSCIENCE

Sidero Biosciences, LLC (Sidero) is a clinical stage biotechnology company advancing disruptive technologies targeting human digestive health. Our technologies utilize the SideroSorb platform, which delivers beneficial proteins/complexes directly to the gastrointestinal (GI) tract to ameliorate human disease... Sidero is dedicated to provide a safe, effective, and economical iron therapy to alleviate iron deficiency for all peoples of the world... Sidero is based on intellectual property developed at The Pennsylvania State University's Hershey Medical Center in Hershey, Pennsylvania. Sidero is developing novel biotherapeutics to treat gastrointestinal system disorders with significant unmet medical need. Sidero is initially targeting the high-value Iron Deficiency market, providing one of the fastest growing investment returns in medical research. The patented Siderosorb platform delivers a therapeutic protein/complex directly to the intestine by oral ingestion in a pill, liquid,..

Also known as: Sidero, Sidero Bioscience LLC

Primary location: Hummelstown United States